Sfoglia per AUTORE
ADDEO A
Collezione ASL Torino 4

  

Items : 3

Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study. in International immunopharmacology / Int Immunopharmacol. 2022 Sep;110:108985. doi: 10.1016/j.intimp.2022.108985. Epub 2022 Jun 28.
2022
ASL Torino 4
AOU San Luigi di Orbassano

Pinato DJ; Bainbridge H; Hicks A; Chan S; Barone G; Escriu C; Signori A; McKenzie H; Addeo A; Cortellini A; Comins C; Cave J; Muthuramalingam S; Cantale O; Banna GL; Ottensmeier C; Gomes F;

International Survey on Frailty Assessment in Patients with Cancer. in The oncologist / Oncologist. 2022 Oct 1;27(10):e796-e803. doi: 10.1093/oncolo/oyac133.
2022
ASL Torino 4
AOU San Luigi di Orbassano

Garetto L; Maltese G; O'Carroll E; Musolino N; Bambury K; Battisti NML; Haydock MM; Cantale O; Banna GL; Addeo A; Gomes F;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.
2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Russano M; Porzio G; Tiseo M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Metro G; Spinelli GP; Passiglia F; Migliorino MR; Ricciardi S; Pecci F; Zoratto F; De Tursi M; Di Marino P; Mansueto G; Tuzi A; Gori S; Della Gravara L; Rastelli F; Chiari R; Macerelli M; Marchetti P; Gelibter A; Antonuzzo L; Berardi R; et alii...